TICH-3 trial: Tranexamic acid for IntraCerebral Haemorrhage 3
A study to assess the clinical effectiveness of tranexamic acid (TXA) after Intracerebral Haemorrhage (ICH) and determine whether TXA should be used in clinical practice.
The WIIIRED study has now ended, and these pages are no longer being updated.
Thank you for your interest. For any further information, please contact eoin.macdonald-nethercott@nhs.net
Please select a location on the homepage in order to see recruitment instructions.
Back to homescreen